LivaNova Cardiopulmonary President Marco Dolci to retire Dec 31, 2023, receives €860,000

LivaNova PLC

Marco Dolci, President of the Cardiopulmonary business unit, announced retirement effective Dec 31, 2023.
Retirement settlement includes €860,000 payment under Italian law and continued vesting of unvested equity awards.
Mr. Dolci will remain in his role through the retirement date to support transition; he joined LivaNova in March 2017.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marco Dolci

President, Cardiopulmonary Business Unit

LIVN · LivaNova PLC

Effective: 2023-12-31
Filed: September 21, 2023, 7:59 PM ET

On September 21, 2023, LivaNova PLC (the “Company”) reported that Marco Dolci, President of the Company’s Cardiopulmonary Business Unit, announced his intent to retire formally from the Company on December 31, 2023 (the “Retirement Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Marco Dolci departed as President, Cardiopulmonary Business Unit at LivaNova PLC.

Action: retire
Role: President, Cardiopulmonary Business Unit

Exact text from the filing

On September 21, 2023, LivaNova PLC (the “Company”) reported that Marco Dolci, President of the Company’s Cardiopulmonary Business Unit, announced his intent to retire formally from the Company on December 31, 2023 (the “Retirement Date”).

View on SEC.gov

LivaNova PLC filing history →

Source: SEC EDGAR

accession 0001639691-23-000087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.